Valuation: Bonesupport Holding AB

Market Cap 15.81B 1.64B 1.43B 1.32B 1.22B 2.32B 156B 2.36B 6.19B 76.84B 6.14B 6.01B 268B P/E 2026 *
52x
P/E 2027 * 31.9x
Enterprise Value 15.19B 1.57B 1.38B 1.27B 1.17B 2.23B 150B 2.27B 5.95B 73.86B 5.9B 5.78B 257B EV / Sales 2026 *
10.1x
EV / Sales 2027 * 7.49x
Free-Float
85.24%
Yield 2026 *
0.6%
Yield 2027 * 0.9%

Last Transcript: Bonesupport Holding AB

1 day+25.07%
1 week+29.44%
Current month+25.56%
1 month+20.62%
3 months+18.95%
6 months+42.23%
Current year+43.02%
1 week 223.9
Extreme 223.9
268.4
1 month 196
Extreme 196
268.4
Current year 167.55
Extreme 167.55
272.5
1 year 167.55
Extreme 167.55
345.8
3 years 111.8
Extreme 111.8
404.4
5 years 34.65
Extreme 34.65
404.4
10 years 12.06
Extreme 12.06
404.4
Manager TitleAgeSince
Chief Executive Officer 49 31/08/2025
Director of Finance/CFO 63 31/10/2018
Chief Operating Officer 51 30/11/2021
Director TitleAgeSince
Director/Board Member 68 31/12/2009
Chairman 70 14/12/2016
Chairman 71 13/05/2019
Change 5-day change 1-year change 3-year change Capi.($)
+25.07%+29.44% - - 1.52B
+0.76%+6.92%+21.94%-3.54% 67.44B
+0.52%-3.06%+46.97%+219.12% 53.98B
-2.79%+32.50%+32.50%+32.50% 41.77B
+0.99%+6.05%-48.96%-52.97% 41.15B
-0.72%-5.16%+47.93%-27.69% 29.58B
+3.74%+5.60%+135.28%-35.59% 29.28B
+1.07%+4.14%+75.14%+90.95% 23.43B
+0.17%+8.48%+4.86%+185.45% 19.11B
+1.14%+2.26%+68.00%+135.40% 16.82B
Average +2.58%+1.29%+42.63%+60.40% 35.84B
Weighted average by Cap. +0.17%+1.05%+36.38%+52.26%

Financials

2026 *2027 *
Net sales 1.5B 155M 136M 125M 116M 220M 14.79B 223M 586M 7.28B 582M 569M 25.36B 1.98B 205M 180M 166M 153M 291M 19.61B 296M 777M 9.65B 771M 754M 33.61B
Net income 309M 32M 27.98M 25.8M 23.85M 45.34M 3.05B 46.1M 121M 1.5B 120M 118M 5.24B 508M 52.58M 45.98M 42.4M 39.19M 74.51M 5.02B 75.75M 199M 2.47B 197M 193M 8.6B
Net Debt -613M -63.49M -55.52M -51.2M -47.33M -89.98M -6.06B -91.48M -240M -2.98B -238M -233M -10.39B -948M -98.13M -85.81M -79.13M -73.15M -139M -9.37B -141M -371M -4.61B -368M -360M -16.06B
Logo Bonesupport Holding AB
Bonesupport Holding AB is a Sweden-based orthobiologics company. It develops and commercialize injectable bioceramic bone graft substitutes which remodel to host bone and have the capability to elute drugs directly into the bone void. The marketed synthetic bone graft substitutes are CERAMENT BVF, CERAMENT G and CERAMENT V, which are based on the CERAMENT technology platform. The products are commercially available in Europe and the United States, as well as in India, Malaysia, Oman and Singapore. The products are developed to treat patients with fractures and bone voids caused by trauma and related surgery, as well as caused by infection or diseases, such as chronic osteomyelitis, revision arthroplasty and infected diabetic foot.
Employees
160
Date Price Change Volume
09/07/26 SEK 234.98 +4.71% 6,976
08/07/26 SEK 224.40 -4.07% 1,299
07/07/26 SEK 233.91 +1.38% 23,652
06/07/26 SEK 230.73 +2.89% 10,550
03/07/26 SEK 224.25 +5.06% 9,328
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
240.00SEK
Average target price
371.83SEK
Spread / Average Target
+54.93%

Quarterly revenue - Rate of surprise